Top 10 Primary Care Drugs Approved in Early 2017
Click through this slide summary for a look at some of the more significant approvals so far for primary care.
Just shy of 3 months into the new year, the FDA has already granted a number of new drug approvals and new indications for drugs already approved. Scroll through the slides above for a look at some of the more significant recent approvals for primary care.For a quick review of last year’s approvals, go to Top 20 Primary Care Drugs Approved in 2016. SOURCESCenterWatch: 2016 FDA Approved DrugsDrugs.com: New Drug ApprovalsÂ
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
